Title
Category
Credits
Event date
Cost
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Yuri Fedoriw, MD, provides a general background of cancer pathology and tissue diagnosis. The development of testing methods and their application will be discussed, as will the limitations and challenges of cancer classification.
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Jethro Hu, MD, will review the rationale and current evidence supporting the potential role of a ketogenic diet for brain tumor patients, focusing on a recently completed phase 1 safety and feasibility trial.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Cancer patients and survivors have higher rates of anxiety and depression compared to the general population. Cancer-related anxiety and depression may significantly reduce wellbeing and result in adverse treatment and survival outcomes. This lecture will provide an overview of psychotherapeutic modalities that can treat cancer-related distress.
  • Advanced Practice Provider
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Nancy Vogler, AGPCNP-BC, will discuss the common types of anemia and thrombocytopenia, common causes of each, how the non-hematology provider can best manage patients with anemia and/or thrombocytopenia, and when to refer to hematology.
  • Advanced Practice Provider
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Oral oncolytics have revolutionized cancer care over the last two decades. Although they provide a more convenient & often more tolerable alternative to traditional chemotherapy agents, their unique mechanisms of action lead to a wide range of potential side effects. In this CPP panel discussion, Aimee Faso, Bianka Patel, and Kevin Chen will discuss the considerations when managing side effects for patients receiving oral oncolytic treatments for various solid tumor and hematologic malignancies.
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.25 ASRT
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Marc Bjurlin, DO, MSc, FACOS, gives a contemporary overview of prostate cancer screening with a focus on prostate cancer in men in North Carolina.
  • 0.75 NCPD/CNE
  • 1.00 Participation
$0.00
In this course, Mary Dunn, MSN, RN, NP-C, OCN, will provide a general overview of Prostate Cancer. The audience will learn about basic pathophysiology and epidemiology as it relates to both local and advanced disease. This course will then provide insight into the pros & cons of prostate cancer screening as well as the accepted diagnostic procedures & scoring.
  • 0.75 NCPD/CNE
  • 1.00 Participation
$0.00
In this course, Mary Dunn, MSN, RN, NP-C, OCN, will go into more detail for treatment options and considerations for treating localized prostate cancer and the management of side effects.
  • 0.75 NCPD/CNE
  • 1.00 Participation
$0.00
In this course, Mary Dunn, MSN, RN, NP-C, OCN, will discuss the different treatment options for advanced prostate cancer as well as considerations for management side effects and maximizing a survivor’s quality of life.
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ASRT
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
09/25/2024
$0.00
Matthew I. Milowsky, MD, FASCO, will present on Update in Bladder Cancer

Pages